When Kay Wesley moved from the world of dot com to work as global digital director at AstraZeneca, she realised that pharma was transforming for digital at a rather different pace.
Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo
